Since the first description of invasive aspergillosis as an sacs and lungs of a jackdaw (table 1) . The first human case of aspergillosis was described in 1842 by Bennett in Edinburgh opportunistic infection in 1953 [1] , there has been a substantial increase in the number of cases documented at autopsy in all [6] . He described what he saw microscopically in the sputum of a patient with several aspergillomas in tuberculous cavities developed nations. The most recent figure from one major teaching hospital in Frankfurt, Germany, showed a 14-fold as a cryptogamic plant. The same year, Rayer [7] described infection of the pleura increase in the number of cases over the years 1978 -1992 ; 4% of all patients autopsied were found to have invasive asperby a mold, again not identified, and Gairdner [28] reported a similar case in 1853. Virchow [29] described four cases of gillosis in the last year of this survey [2] . A national autopsy survey conducted in Japan from 1970 to 1995 showed that the bronchial and pulmonary aspergillosis in 1856. Other early descriptions are summarized by Rénon in 1897 [30] , by Cawincidence of invasive aspergillosis increased from 0.4% to 1.4% during that period [3] . The substantial worldwide use of flucoley in 1947 [19] , and by Hinson et al. in 1952 [21] . Rénon recognized that some cases occurred following other diseases nazole, which has no clinically useful activity against invasive aspergillosis, has not reduced the number of cases of this infecand that Aspergillus could invade the lung in addition to inhabiting tuberculous cavities or other cavities [30] . Many tion, which remains the most common invasive mold infection worldwide.
early cases (possibly only colonization) were described in pigeon-crammers or hair combers (for wigs). Cawley also There has been a substantial increase in the number of patients at risk of developing invasive aspergillosis, for many remarked on the association between aspergillosis and certain occupations such as farmers, feed-mill workers, fur cleaners reasons, including (1) the advent of AIDS; (2) the development of new intensive chemotherapy regimens for solid tumors, difwho used rye flour, threshers, and those in contact with silos or grains [19] . ficult-to-treat lymphoma, myeloma, and resistant leukemia; (3) a year-on-year worldwide increase in the number of solid organ
Other landmarks in the description of aspergillosis are shown in table 1. It is of interest that among deep, invasive forms of transplant recipients, now numbering approximately .5 million annually; and (4) increased use of immunosuppressive regiaspergillosis, only pulmonary and renal diseases were described in the nineteenth century. Likewise, superficial aspergillosis, mens for other autoimmune diseases such as systemic lupus erythematosus. As other supportive care is improved and most including otomycosis and keratitis, was described as early as 1844. As with many early descriptions, details are often bacterial infections are successfully treated, the importance of invasive aspergillosis has increased so that it is now a major sketchy, but these early observations were of great importance in the initial recognition of the pathogenic potential of Aspergildirect or contributory cause of death at leukemia treatment centers and bone marrow transplantation and solid organ translus, especially in immunocompetent patients. Disseminated aspergillosis was described early in the twentieth century, but plantation centers. This article reviews the current state of knowledge regarding invasive aspergillosis.
the histological appearances were almost always granulomatous, and the disease occurred in apparently immunocompetent patients. It was not until the introduction of corticosteroids and History cytotoxic chemotherapy in the 1950s that the first cases of invasive pulmonary aspergillosis, the opportunistic infection The first description of aspergillosis in animals was provided we now clinically recognize, began to appear. by Mayer in 1815 [4] , who observed the infection in the air [7] 1842 Rayer Pleural aspergillosis [8] 1844 Mayer Aspergillus otomycosis [9] 1863 Fresenius Clear species description of A. fumigatus (isolated from air sacs and bronchi of a great bustard) [10] 1879 Leber Aspergillus keratitis following chaff entering the eye [11] 1886 Boströem Cutaneous aspergillosis [12] 1887 Popoff Allergic pulmonary disease caused by Aspergillus [13] 1890 1953 Rankin Invasive pulmonary aspergillosis as an opportunistic infection (during neutropenia) [22] 1955 Zimmerman Invasive aspergillosis in infancy [23] 1959 Finegold, Will, and Murray Classification of invasive aspergillosis [24] 1964 Newman and Cordell Postoperative aspergillus endocarditis [25] 1966 Milosev et al.
Mycology
Paranasal aspergillus granuloma in Sudan [26] 1970 Young et al.
Comprehensive description of pathology of invasive aspergillosis, with clinical correlation [27] 1983 Katzenstein, Sale, and Greenberger Allergic aspergillus sinusitis from a central structure, resembled an aspergillum (a brush or omycotina because most of these molds do not have a sexual reproductive phase. The taxonomy of species within the Asperperforated globe used for sprinkling holy water); therefore, he named the genus Aspergillus. He described experiments of gillus genus is gradually undergoing revision with the use of molecular taxonomic methods and is not complete. The most culturing fungi from spores both in gardens and on pieces of melon. His A. glaucus require high concentrations of glucose for optimum growth. Only pathogenic species are capable of growth at 35Њ -new species continue to be described [35] .
Although Aspergillus is a separate genus, it is closely related 37ЊC, and A. fumigatus in particular is capable of growth at §50ЊC. Recent comparative work from a large retrospective to Penicillium species in the fungal kingdom. Aspergillus species are ascomycetes classified in the form subdivision Deuterseries established that a higher yield was obtained by using 783 CID 1998; 26 (April) Invasive Aspergillosis mycological media rather than standard bacteriological media lus; the most rapidly growing organism is A. fumigatus. Physiological and pharmacological concentrations of hydrocortisone in the clinical setting [36] , and this procedure is recommended accelerate the growth rate of A. fumigatus and A. flavus by whenever a fungal infection, including aspergillosis, is consid-30% -40%. In vitro, in the presence of hydrocortisone, A. fumiered diagnostically possible. Most isolates of A. fumigatus are gatus has a doubling time of 48 minutes and a hyphal extension capable of growth at oxygen tensions as low as 0.1% O 2 [37] , rate of 1 -2 cm/h [39] . Growth rate is therefore likely to be and instances when isolates would grow only on anaerobic one key determinant of the rate of progression of disease and, plates have been recorded. Additional work to optimize media possibly, of pathogenicity. for the growth of Aspergillus is warranted.
In addition, A. fumigatus has some other characteristics that The organism grows initially as a small, fluffy white colony may contribute to its pathogenicity. These characteristics inon the surface of agar. Spores usually develop within 36 - clude very small spore size (3 -5 mm), which enables the spores 48 hours of incubation at 30Њ -37ЊC for the major pathogenic to penetrate deeply into the lung. Spores are capable of withspecies. For unusual species, it can take many more days, and standing extraordinary atmospheric conditions, probably by sometimes weeks, for spores to appear, a circumstance that virtue of the hydrophobic protein-coat layer, which may help delays identification. Potato dextrose agar is particularly useful protect them from host defenses [41 -43] . Of all the pathogenic for inducing sporulation. [59, 60]. Extensive work with the alkaline protease of A. fumiUntil recently, it has not been therapeutically important to gatus with use of single or double deletants in carefully condetermine which species of Aspergillus is causing disease betrolled animal model experiments has failed to show the imporcause no differences in outcome have been noted between intance of elastase (alkaline protease) in invasive aspergillosis fections caused by different species. Recently, however, some
[61]. However, one protease was able to induce pulmonary differences in susceptibility to itraconazole and other azoles epithelial cell detachment as well as proinflammatory cytokine have been noted between species (author's unpublished data;
release [62] . Similarly, ribotoxin does not appear to be im- [38] ). Thus, it may be more important now than previously to portant in the pathogenesis of aspergillosis [51] . rapidly identify species or to test isolates for susceptibilities to At least four different phospholipases are produced by make an optimal therapeutic decision.
A Gliotoxin has been shown to reduce macrophage and neutrodepending on the medium used [39] . Spores incubated in approphil phagocytosis [54] . Gliotoxin can also induce apoptosis priate moisture conditions and temperature swell to approxi- [56] , but whether gliotoxin contributes to pathogenesis has mately four-to-eight times their original volume. Their hynot yet been established. Phthioic acid is produced in small drophobic protein coat is replaced by another cell wall exterior.
quantities by a very small number of A. fumigatus isolates and As hyphae appear, the logarithmic-phase growth begins. In vitro, could conceivably contribute to granuloma formation, as it may hyphal extension and overall fungal mass increase logarithmido in tuberculosis, but it is unlikely to be a major virulence cally until Ç24 hours, when the growth rate starts to plateau [39] .
determinant. Branching of hyphae occurs early, and in shaking conditions in Aspergillus produces a number of superoxide dismutases vitro, the organism takes on the appearance of multiple small
[63], at least two catalases [64 -66] and mannitol [67 -69] . balls. At the liquid-air interface in static culture, a mycelial mat These substances may protect the organism from damage due is typically formed. These growth patterns probably reflect, in to singlet oxygen, hydrogen peroxide, hydroxyl radical, and part, the branching characteristics of each isolate.
other free radicals produced by phagocytes. Most species of Aspergillus are incapable of growth at 37ЊC,
Host Factors
a key characteristic that distinguishes pathogenic species from nonpathogenic species [40] . There are also discernible differ-A. fumigatus is an unusual pathogen in immunocompetent patients, although many cases of A. fumigatus infection in such ences in the growth rate between different species of Aspergil- Denning CID 1998; 26 (April) by treatment with granulocyte colony-stimulating factor [76] and granulocyte-macrophage colony -stimulating factor (in vitro) [77] . Administration of IFN-g also improves monocyte and neutrophil function [76, 78] . Emerging data also indicate that T cell function may be important, particularly in the more chronic forms of invasive aspergillosis [79] . An interaction between neutrophil dysfunction and T helper cells via IL-4 has been observed in experimental models of invasive aspergillosis, and this interaction could have implications for human disease [79] . In patients with invasive disease, Th 2 cell responses predominate over Th 1 cell responses, and successful therapy could necessitate reversing these T helper cell responses. There is also evidence for acquired immunity, possibly mediated in part by macrophages [80] . In addition, unfiltered marijuana smoke may yield substantial the lungs, and presumably the nose, are macrophages, which quantities of Aspergillus spores and patients at risk for aspergilare capable of ingesting and killing spores [70] . Both monolosis should be advised of this possibility. cyte-derived and resident macrophages contribute to spore inVarious molecular typing systems for A. fumigatus have been gestion and killing. Hyphae are primarily killed by neutrophils developed over the last 7 years [85] . These have proven to be [70, 71] , with some contribution from monocytes [72] and robust and useful in evaluating the epidemiology of invasive possibly macrophages. Swollen spores and hyphae bind comaspergillosis. It is clear that there is widespread dispersal of plement [73] . Hyphae are too large to be ingested, and theregenotypes of A. fumigatus around the world; for example, idenfore, killing proceeds extracellularly; this process is unlike killtical genotypes cause disease in the United States and Europe ing of most bacteria and Candida albicans, in which the [86 -89] . A complete population genetic analysis of the species organisms are first internalized. As in patients with leprosy,
has not yet been conducted, although the tools are now availthe histological response in patients with aspergillosis ranges able to do so. The majority of infections are caused by a single from a florid granulomatous response to few organisms (figure genotype of A. fumigatus; occasionally, however, two or more 1) to a minimal tissue response around extensive necrosis ingenotypes have been identified in patients. The latter finding vaded by extensive networks of hyphae (figures 2A and B), is particularly true for patients with aspergillomas. There does depending to a great extent on the degree of immunologic not appear to be a group of related genotypes that are more or deficit. Neutropenia and dysfunctional neutrophils (which ocless pathogenic [89] , but such analyses have not been percur in patients with AIDS [74] and chronic granulomatous formed on large numbers of isolates from minimally immunodisease [75] ) are both important risk factors for invasive aspercompetent patients, in whom prominent virulence determinants gillosis but lead to different pathology.
are most likely to be identified. This relatively simple scheme is, of course, more complex than it first appears because of the influence of various cytokines, growth factors, and corticosteroids. Corticosteroids sub- what the infectious inoculum for aspergillosis is, but this factor they arrive at the hospital, partly because of breaks in airflow may depend upon the host.
(e.g., during the provision of food or during bed linen changes), It is also not clear what the incubation period between expoand partly because patients leave these protective environments sure to inoculum and the development of disease is. For one to undergo investigations. heart transplant recipient, it was documented that there was a
In addition, the sudden release of large quantities of spores 3-month time lag between the identification of Aspergillus in that occurs on cleaning or when spores are shed from clothes bronchoalveolar lavage fluid and the subsequent development may be undetectable by routine spore counts but are particularly of disseminated disease [90] . It is also notable that for neutrodangerous. The effects of minibursts of spores can be minipenic patients, invasive aspergillosis virtually never manifests mized by increasing the air change rate in protective environbefore the 12th day of profound neutropenia [91] , although ments [100]. However, patients at particularly high risk such as many patients have sinus or airway colonization with Aspergilbone marrow transplant recipients and liver and lung transplant lus on arrival at the hospital [92] . In a case in which a laparotrecipients, neutropenic patients, and extensively burned paomy wound became infected by A. fumigatus within 48 hours tients should be housed in hepafiltered environments if possiof transfer of the patient from one hospital to another, DNA ble. Aspergillus has been found in showerheads and hot water typing showed that the causative organism was in the air of faucets, which could represent another risk for these patients the intensive care unit of the receiving hospital, a finding that [101] . suggests an extremely short incubation period [93] .
Because Aspergillus is ubiquitous in the air and environment, the primary means of control is by filtering the air to remove all A. fumigatus spores, by using pharmaceutical agents active Prevention and Prophylaxis against Aspergillus, and (conceptually) by administering a vaccine. Although control of air is possible within the hospital, In the hospital setting, patients at profound risk for aspergilthis measure is expensive, and it does not generally include all losis should not be given pepper or spices that have not been patients at risk. For example, patients with AIDS and those sterilized [94] . Potted plants and shrubs probably pose some receiving corticosteroids are generally not housed in heparisk to patients, particularly if such plants are in the immediate filtered environments, which means that prevention may be vicinity of patients who are highly immunocompromised [84] .
possible for the highest-risk groups for limited periods but Local construction work is thought to be a major risk factor is not currently possible for all groups at risk in hospitals. for highly immunocompromised patients such as bone marrow Furthermore, patients at continuing risk, such as those who and liver transplant recipients and those with profound neutrohave undergone solid organ transplantation, are discharged penia [95] , and some data suggest that complete separation of home, and the home environment is a substantial source of construction areas from clinical areas may reduce the risk to
Aspergillus spores. these patients [96] . The use of hepafiltration [97] and, in particSeveral different approaches to prophylaxis for invasive asular, laminar air flow [98, 99] reduces the risk of invasive pergillosis have been attempted [94, 102] . No study has yet aspergillosis but does not reduce it to zero, probably partly because patients are already colonized by Aspergillus when convincingly shown that any means of prophylaxis is com-/ 9c4a$$ap40 03-10-98 10:26:38 cida UC: CID • Keratitis and/or endophthalmitis Recent data are consistent with a protective effect of itracona-
• Cutaneous infection (e.g., burn-associated aspergillosis)
zole solution [105] . The cost-benefit equation varies with the aspergillosis. However, it is unlikely that prophylaxis will be Infection predominantly in immunocompromised hosts used for all patient groups at risk, and cases of invasive asper-
• Primary cutaneous aspergillosis, especially in leukemic children • Pulmonary aspergillosis gillosis will continue to occur.
Acute invasive
There is presently little likelihood that a vaccine for the Chronic necrotizing aspergillosis prevention of invasive aspergillosis will be developed, although to require intermittent large doses of corticosteroids. However, there are several impediments to the development of a vaccine. One impediment is the fact that humoral immunity appears to associated mortality that ranges from 50% to 100% despite play an insignificant part in protection against invasive aspertherapy [107] . gillosis, although patients who recover from invasive aspergillosis develop antibodies to Aspergillus [106] . Whether certain Clinical Features antibodies to Aspergillus act as opsonins in vivo is unclear.
More detailed work on identifying major Aspergillus anti-
Patterns of Disease
gens and their interactions with various parts of the immune The incidence of invasive aspergillosis varies remarkably system is warranted to try to identify protective immunodomifrom center to center, and within centers, the disease tends to nant epitopes. Further studies of the role of T helper cells may occur sporadically. Approximate incidence figures for different be important. Even if a vaccine were only partially protective patient groups are shown in table 2. and slowed the rate of disease progression, allowing aspergilloThe portals of entry for Aspergillus include the respiratory sis to be diagnosed and successfully treated, this effect would tract, damaged skin or other operative wounds, the cornea, be of substantial importance with respect to a disease with an and the ear. Infection arising from the gastrointestinal tract is possible but has never been clearly documented. Whichever the portal of entry is, that site is usually affected. The majority clinical patterns in the major patient groups. In the following Systemic lupus erythematosus 1 sections, the major body sites of disease will be described.
Autologous BMT with growth factors õ1
Pulmonary Disease
NOTE. Data are from [108] . BMT Å bone marrow transplantation. * Distinguishing colonization from disease is particularly difficult in these
The clinical presentation of invasive pulmonary aspergillosis patients. † Lifetime incidence.
varies with the patient group, as does the rate at which the / 9c4a$$ap40 03-10-98 10:26:38 cida UC: CID disease progresses [109 -129] . The most immunocompromised pneumothorax is an occasional presenting feature, and sharp chest pain with dyspnea is typical. The symptoms and signs patients are those least likely to have symptoms, and progresof pulmonary zygomycosis are indistinguishable from those of sion is fast (e.g., 7 -14 days from onset to death). Conversely, invasive aspergillosis. the least immunocompromised patients, such as diabetics or
The prognosis of focal disease (and, in particular, nodular immunocompetent patients, usually have indolent symptomatic disease) is much more favorable than that of diffuse and bilatpresentations that progress slowly (e.g., 2 -3 months from onset eral disease, as focal disease tends to progress more slowly to diagnosis). [111, 118, 130 -131] . Resection is one therapeutic option that Acute invasive pulmonary aspergillosis. Approximately is not available to patients with bilateral diffuse or extensive 25% -33% of patients initially have no symptoms attributable disease. The only major problem for patients with focal disease to invasive pulmonary aspergillosis. As the disease progresses, is hemoptysis, which is often life-threatening and may occur symptoms appear. Early symptoms are cough (usually dry) and without warning [112, 121, 124, 131] . fever. Corticosteroid-treated patients often do not have fever, and low-grade chest pain, which may be pleuritic but is more Hypoxemia is usual in patients with diffuse disease, and hypocapnea is often present. WBC counts are usually normal, commonly dull and nonspecific, is a frequent finding. A pleural rub is sometimes heard. Hemoptysis can occur, although it is as is plasma chemistry. Elevated levels of bilirubin and lactate dehydrogenase are occasionally seen but are nonspecific findrarely a presenting feature. Dyspnea is more common in patients with diffuse disease. The presentation in some patients ings. Coagulopathy may be present. The serum fibrinogen level is typically elevated in neutropenic patients with acute leukemia is akin to that of pulmonary embolism. In neutropenic patients, / 9c4a$$ap40 03-10-98 10:26:38 cida UC: CID Early in the course of rapidly progressive invasive pulmonary aspergillosis, plain radiographs are often (falsely) negative, and thus high-quality CT scans of the chest can play a major role in early diagnosis [118, 127, 133, 134, 136, 138 -142] . In neutropenic patients the most distinctive early lesions are small nodules and/or small pleural-based lesions with straight edges and surrounding low attenuation (the halo sign) (figure 4). There may be only one lesion, but often there are several. As the disease progresses, the nodules may cavitate (often as the neutrophil count recovers), resulting in the air crescent sign. Both the halo and air crescent signs are highly distinctive for invasive fungal disease of the lung, usually due to Aspergillus but also occasionally to a Mucorales, Trichosporon, Blastoschizomyces, or Fusarium. Pathoradiological correlative studies have conclusively shown that these lesions represent infarcted lung tissue full of hyphae that ramify beyond the area of infarction.
Chronic invasive pulmonary aspergillosis. Chronic invasive pulmonary aspergillosis is less common than acute disease. Underlying conditions include AIDS [121, 143] , chronic granulomatous disease [144] , diabetes mellitus [145] , alcoholism [145] , and corticosteroid therapy for chronic pulmonary disease such as sarcoidosis [146 -148] ; however, many patients do not have any immunocompromising factors [149 -151] . In relatively immunocompetent patients with chronic invasive pulmonary aspergillosis, symptoms are more prominent, extend over weeks or months, and are similar to those of an aspergilloma. [127]. The C-reactive protein level is often elevated, but its specificity as a marker for either fungal infection or invasive aspergillosis is in doubt.
The appearances of invasive aspergillosis on plain chest radiographs are extremely heterogenous [109, 111 -117, 121 -123, 129, 131 -137] . Cavitation and pleural-based, wedgeshaped lesions are the most distinctive appearances of invasive aspergillosis. Nodular shadows, with and without cavitation, thick-or thin-walled cavities (in patients with AIDS and chronic necrotizing pulmonary aspergillosis), and alveolar consolidation that coalesces over time to form small nodules are typical. Diffuse, usually lower-lobe, fine shadowing is also seen (figure 3). Pleural effusions are rare. In the context of Cavitation that expands over time with surrounding consolidation in an area of lung that either did not have a cavity or previously had a small one is seen on radiographs. It can sometimes be difficult to distinguish an aspergilloma from chronic invasive pulmonary aspergillosis, particularly if a previous chest radiograph is not available. A cavitating lung tumor can have similar appearances.
Definitive diagnosis requires demonstration of Aspergillus hyphae in lung tissue and a culture-positive respiratory specimen. However, hyphae often are scant, and only granulomas are found, with cultures yielding Aspergillus. Different histological patterns have been described, including angioinvasive necrotizing granulomatous pneumonia, a granulomatous bron- 
cartilage. Patients with pseudomembraneous aspergillus tra-

Aspergillus Tracheobronchitis
cheobronchitis have shaggy greyish linings of the whole trachea Aspergillus tracheobronchitis is proportionately more comand bronchial wall. Therapy with an azole appears to be supemon in patients with AIDS [153] and in lung transplant recipirior to that with systemic amphotericin B for this disease [154] . ents than in other immunocompromised patients [129, 154] ;
The role of aerolized amphotericin B has not been well evaluhowever, Ç25% of patients are not apparently immunocomated but appears minor, and this agent may cause significant promised [153, 155] . Airway disease due to Aspergillus ranges bronchospasm. from relatively mild tracheobronchitis with excess mucus production and inflammation to ulcerative tracheobronchitis with ulcers (often around the suture line in lung transplant recipients)
Invasive Aspergillus Sinusitis
and extensive pseudomembranous tracheobronchitis [154] .
Distinguishing infection from colonization in lung transplant
The term invasive aspergillus sinusitis embraces at least three distinct disease entities. Acute rhinosinusitis is a relatively recipients can be problematic [156] .
Approximately 80% of patients with aspergillus tracheocommon manifestation of invasive aspergillosis in neutropenic and bone marrow transplant recipients [119, 159 -162] (table bronchitis are symptomatic, although symptoms may be mild or reasonably attributable to another cause such as rejection 4). Invasive aspergillus sinusitis appears to be extremely uncommon in solid organ transplant recipients [163] . Chronic after lung transplantation. These symptoms include cough, fever, and dyspnea (each present in õ50% of patients); chest invasive aspergillus sinusitis occurs in healthy or only mildly immunocompromised patients [164 -167] , and a variant of this pain; and hemoptysis. As the disease progresses, symptoms become more common and more severe. Patients with pseudodisease, paranasal aspergillus granuloma, is seen in the tropics [168, 169] . A. flavus is proportionately more common as a membranous aspergillus tracheobronchitis may develop a unilateral monophonic wheeze or stridor, reflecting obstruction of cause of aspergillus sinusitis [163] . Acute invasive aspergillus rhinosinusitis. Early symptoms the lumen of the airway with necrotic material and fungal material [157] . Many patients die of respiratory insufficiency are nonspecific and easily mistaken for possible bacterial infection [159] . Fever, cough, epistaxis, and headache are common. secondary to occlusion of the airway; others develop disseminated disease in the last few days of life. Occasionally, perforaOther occasional symptoms include nasal discharge, sinus pain, and sore throat. Findings on examination of the anterior nares tion of the trachea or bronchi occurs.
A chest radiograph is usually normal early in the course of may initially be unremarkable. A careful search for insensitive areas with decreased nasal blood flow that precedes frank crustdisease, but consolidation may occur later. CT findings include peribronchial consolidation and centrilobular nodules [158] , ing or ulceration is particularly important. Invasive aspergillus sinusitis is frequently the only focus of aspergillus disease, but these findings are not specific. Performing bronchoscopy with bronchial biopsy, microscopy, and culture is the only although local extension to the palate [170, 171], orbit, or brain is common and relatively rapid. Aspergillus sinusitis may occur means of making the diagnosis before death (figure 5). Biopsy of loose material in the tracheal lumen will often reveal necrotic concurrently with pulmonary aspergillosis.
sinusitis. In addition, early cases are similar in presentation to saprophytic aspergillus sinusitis and can be distinguished only by radiographic and histopathologic examination of the sinus mucosa and/or bone. As the disease progresses, usually over months, the clinical features of local involvement become apparent. Visual symptoms are common and include diplopia, unilateral blindness, pain in the eye, and proptosis. Headaches, loss or impairment of smell, and the features of chronic sinusitis (e.g., nasal stuffiness) are also common. Fever is almost universally absent. The radiological features of this disease are similar to those of acute disease [166, 174] . Bony destruction may occur without direct fungal invasion, apparently due either to a ''pressure'' effect or to local toxin production (speculative). However, bony invasion by hyphae may be underrecognized histopathologically because of the nature of the surgery required to remove abnormal tissue. Aspergillus sphenoid sinusitis requires particular mention because of its frequent devastating complications, which inPlain radiographs of the sinuses are insensitive and do not allow distinction between bacterial and fungal infection [159, clude major visual disturbance, brain abscess, or stroke and/or death due to involvement of the carotid artery [175 -162] . CT scans show fluid opacification of the sinuses (figure 6), and any bony destruction and spread into adjacent tissues 178] . Approximately 10% of all cases of sphenoid sinusitis are due to Aspergillus, the commonest fungal pathogen [176] . are well visualized. MRI scans also are useful. T 1 -weighted images tend to appear similar to those associated with bacterial Another intractable complication of aspergillus sinusitis is osteomyelitis of the base of the skull [179] . sinusitis (e.g., they may be isointense or show decreased signal intensity), but T 2 -weighted images show very decreased signal For both forms of chronic invasive aspergillus sinusitis, surgical debridement, followed by prolonged antifungal therapy, is intensity compared with those of bacterial sinusitis, which show increased signal intensity.
required [145] . Chronicity and relapse characterize this disease. The diagnosis can be inferred if typical clinical and radiographic features are present along with a positive culture of a Disseminated Aspergillosis lesion or the finding of characteristic hyphae in tissue, and the diagnosis is confirmed if both are present.
At autopsy, many patients who die of or with invasive aspergillosis have disseminated disease [2, 3, 109, 119, 155, 180 -The cornerstone of treatment is the administration of amphotericin B, as treatment with itraconazole appears to be less 188]. Before death, dissemination is often suspected but rarely proven unless cerebral or cutaneous aspergillosis is diagnosed. effective. Radical surgery may be associated with major complications [145] and appears to offer no survival advantage Jaundice and disseminated intravascular coagulation are often seen in the terminal stages of disseminated aspergillosis; the [172] . Response to treatment, with subsequent relapse during episodes of neutropenia or relapses of leukemia, is typical. If precise reasons for these findings are not well delineated. uncontrolled by a combination of antifungal therapy, recovery from neutropenia, and possibly surgery, local extension to the Cutaneous Aspergillosis palate, facial skin, orbit, or brain, with a fatal outcome, is characteristic.
Cutaneous aspergillosis is most commonly seen in neutropenic patients at intravenous-catheter insertion sites [189 -191] Chronic invasive aspergillus sinusitis. Most patients with chronic invasive aspergillosis have no discernible immunocomor around the catheter site as a result of adhesive dressings applied to the skin [191 -195] . Aspergillosis is one cause of promising factors, although a substantial minority are diabetics, drink alcohol to excess, or have AIDS [121, 145, 164 -167, invasive fungal dermatitis in premature neonates [196] and may occur in children with AIDS [197] . Cutaneous aspergillosis is 173]. The clinical presentation of chronic invasive sinusitis depends on how far the disease has progressed. It cannot be occasionally a manifestation of disseminated aspergillosis [119] , in which case diagnosis of the systemic disease can be distinguished clinically from other fungal causes of chronic / 9c4a$$ap40 03-10-98 10:26:38 cida UC: CID CID 1998;26 (April) Invasive Aspergillosis refractory to treatment with amphotericin B (figure 7). Both cutaneous and burn-associated aspergillosis are clinically indistinguishable from infection caused by the Mucorales unless Aspergillus sporulates, in which case direct microscopy will provide an etiologic diagnosis to the genus level. Surgical or other wounds may also be infected with Aspergillus acquired either perioperatively or postoperatively [93] . This occurrence appears to be relatively common among liver transplant recipients (table 4), perhaps because of the long duration of surgery [201] , large operative site, and the presence of immunosuppression.
Apart from burn-associated aspergillosis, cutaneous aspergillosis responds better to therapy than do most other manifestations of invasive aspergillosis, perhaps because the diagnosis is made rapidly and with confidence [145] . Aspergillus fumigatus growing and sporulating in a burn on a 7-year-old boy with 50% full thickness burns; he later died.
Cerebral Aspergillosis
Cerebral aspergillosis occurs in 10% -20% of all cases of achieved rapidly with microscopic examination and culture of a skin biopsy specimen.
invasive aspergillosis, and only rarely is the brain the sole site of infection [202 -216] . The clinical presentation and pace of The clinical appearance of cutaneous aspergillosis is very similar to that of pyoderma gangrenosum, which is caused progression of cerebral aspergillosis, like pulmonary aspergillosis, vary remarkably with the host group. The most immunomore commonly by Pseudomonas aeruginosa. Initially, an area of raised erythema is present that rapidly increases in size with compromised patients present with nonspecific findings (i.e., alteration in mental status and seizures) shortly before death, accompanying discomfort or pain. The center of the lesion changes from red to purple and finally to black and may ulcerwhereas those slightly less immunocompromised are more likely to have focal features and headache. Fever sometimes ate. Histologic examination reveals invasion of local blood vessels and infarction of the skin, corresponding to the visual occurs but may be attributed to other coexistent infections. Meningism occurs rarely. appearances. The rate of progression of the lesion usually corresponds to the patient's immune status, in that patients without For highly immunocompromised patients, the appearance of cerebral aspergillosis on CT scans is that of one or multiple circulating neutrophils tend to have rapidly progressive disease, whereas those with some neutrophils will have disease that hypodense, well-demarcated lesions (figure 8) [212, 213, 217 -219] . Hemorrhage and mass effect are unusual. For patients progresses over several days.
Aspergillus may also invade burns [97, 198 -200] (table 4) , with normal peripheral WBC counts, the findings of ring enhancement and surrounding edema are more frequent [217] . causing a rapidly progressive necrotic lesion that is usually The scan shows a multiloculated abscess with much surrounding edema. B, T 1 -weighted sagittal image of same patient showing the large abscess and surrounding edema, although it is less obvious than on the T 2 -weighted image.
Unusual Forms of Invasive Aspergillosis
Clearer definition of a hypodense lesion is sometimes obtained with use of intravenous contrast. MRI scans often reveal addiThere are many unusual or rare manifestations of invasive tional lesions without distinctive features (figures 9A and B) aspergillosis (figure 10). Some patients are immunocompro- [213, 220] . These lesions are usually deep-seated and hard to mised, but most are not. Neonates, intravenous drug abusers, access surgically. For less immunocompromised patients, a and patients who have undergone surgery are most commonly mass lesion with surrounding edema and midline shift, usually affected. A summary of these manifestations is provided in with contrast enhancement, is a typical finding [208, 217] . table 5; many of them have been reviewed previously [145, Many of these lesions are frontal or are in the area of the 220], but case reports that update these reviews continue to be cerebellopontine angle.
published. Differential diagnoses depend on the host group. Aspergillus accounts for about half of the cases of brain abscess in bone marrow transplant recipients, and Candida species account for one quarter of the cases [213] . In liver transplant recipients, Aspergillus is the commonest infectious cause of brain abscess, but cerebral infarction and hemorrhage are more common causes of radiological abnormalities [206, 209] . In other solid organ transplant recipients, cerebral aspergillosis and nocardiosis are seen with approximately equal frequency; toxoplasmosis, cryptococcosis, and lymphoma are less frequent. In patients with AIDS, cerebral toxoplasmosis is a much more common cause of cerebral abscess, as is lymphoma. CSF findings are usually abnormal but nonspecific [205, 212] . It is important to rule out other differential diagnoses.
Definitive diagnosis requires biopsy or aspiration of a cerebral lesion, but performance of these procedures is often precluded by a patient's clinical status or by coagulation problems. 
Diagnostic Approaches
The diagnostic approach to invasive aspergillosis in immunocompromised patients offers a useful paradigm for many opportunistic infections, for many reasons. First, invasive aspergillosis occurs in many different host groups, some of whom are at risk for short periods of time and some of whom are at risk for years. Second, invasive aspergillosis is relatively uncommon, and therefore, few physicians or surgeons have sufficient experience with the disease to feel entirely comfortable with either their diagnostic or therapeutic approach. Third, invasive aspergillosis has a variable and nonspecific clinical presentation, so a high index of suspicion is called for. Fourth, there is no single diagnostic test that is either universally applicable or sensitive or specific enough tion is suspected. Detailed radiological evaluation is essential. This should be done with CT or MR imaging within 24 hours after the diagnosis is suspected. Occasionally, Aspergillus afspecimens obtained by aspiration of an abscess, an infected fects other organs of the body, and ultrasonography or CT may sinus, or a pulmonary lesion. be useful in these situations. Once a lesion has been identified While microscopy is moderately sensitive and absolutely and characterized, the best diagnostic approach can then be specific for fungal infection, it does not allow unequivocal decided on. For peripheral pulmonary lesions, the procedure confirmation of the diagnosis of invasive aspergillus infection of choice is needle biopsy or surgical resection of the lesion.
because several other fungi may have similar microscopic and For focal lesions near the hilum and the great vessels in the histological appearances. Such fungi include Scedosporium lung, particularly in neutropenic patients, urgent thoracotomy apiospermum (Pseudallescheria boydii), Fusarium species, and resection should be considered (regardless of the presence Scopulariopsis species, and others. Immunohistochemistry is of neutropenia or thrombocytopenia) because the risk of lifeuseful for distinguishing organisms seen in tissue but not grown threatening hemoptysis is sufficiently high to warrant the relain culture [225] . Culture of Aspergillus from an infected sterile tively low surgical risks. For patients with bilateral alveolar or site provides definitive proof of disease, allows the species multifocal disease in whom surgical resection is impossible, the to be determined, and allows the organism to be tested for best procedures are bronchoscopy and bronchoalveolar lavage.
susceptibility. For this reason, the performance of fungal cultures is appropriate and clinically useful. The yield from specimens is higher if specific fungal media are used [36] even
Microscopy and Culture
though Aspergillus is capable of growth on blood agar and other bacterial media. Fluid obtained by bronchoalveolar lavage, bronchial lavage, or endotracheal aspiration should be processed for microscopy Occasionally, cultures are falsely positive in highly immunocompromised patients, and these results clearly lead to suspior cytology, fungal culture, and any other procedures appropriate for ruling out differential diagnoses (e.g., immunofluocion of disease [118, 126, 128, 129, 224] . In the case of respiratory specimens from patients who are clinically well but highly rescence for Pneumocystis). Combining microscopy and culture will increase the diagnostic yield by 15% -20% [221 -223] immunocompromised (e.g., bone marrow transplant recipients), the clinical presumption should be that such patients over that with culture alone (especially if the patient is receiving empirical antifungal therapy [224] ), and, of course, microshave acute invasive aspergillosis until proven otherwise. copy is relatively rapid ( figure 11 ). The use of special stains for fungi (such as calcafluor white) probably increases the Serology for Aspergillus sensitivity of microscopy, although this has not been systematically studied in the context of invasive aspergillosis. MicrosFluids and aspirates from infected lesions may also be tested by serological methods such as specific ELISA and/or by mocopy is particularly useful in the context of airway and wound aspergillosis because fruiting bodies are sometimes seen, lecular diagnostic methods, although blood is the usual sample tested. The use of serological assays has focused on detecting allowing direct identification of the pathogen with some confidence. Microscopy is also particularly useful for small-volume galactomannan. The early latex agglutination tests were highly and those with profound neutropenia, the course of disease from the appearance of the first clinical or radiological abnorplied only to hematology patients. Routine screening, performed two-to-three times per week, provides the highest detecmality to death is typically 10 -14 days. The diagnosis is often difficult to establish, and several days usually elapse between tion rate. The recently developed G-test, which detects circulating 1,3-b-D-glucan with use of a modification of the consideration of the diagnosis and partial or complete confirmation. A critical window of opportunity may be missed if limulus assay for endotoxin, has a sensitivity of Ç20 pg/mL [228, 229] . Prospective studies of the utility of the G-test have treatment is not started early, with fatal consequences for patients. A culture positive for Aspergillus, microscopy showing shown that it can detect 1,3-b-D-glucan in the context of confirmed invasive mycoses, including invasive aspergillosis, but the presence of hyphae, or a combination of appropriate radiological features are all sufficient to warrant starting therapy in it does not distinguish between species of Candida, Aspergillus, or other major fungi. Sera from patients with aspergillomas patients at risk for this infection. may also be G-test positive [228, 229] , although this condition should be distinguishable on a clinical basis.
Antifungal Agents
Testing for antibodies to Aspergillus has been performed for solid organ transplant recipients as a means of alerting cliniThere are currently only two antifungal agents with activity against Aspergillus -amphotericin B and itraconazole (table cians to a possible diagnosis of invasive aspergillosis. Recently published early data on heart transplant recipients and more 6). The overall success rate with amphotericin B therapy is 34% (table 7) but varies substantially between different host conclusive data on lung transplant recipients [230] suggest that this procedure is another valuable adjunct to assist clinicians groups. Similar response rates are seen with itraconazole. The lipid-associated formulations of amphotericins B appear to be in identifying patients who need further evaluation. Antibodies to Aspergillus may be detectable in other patients with invasive equally efficacious but not more so. Therefore, if a patient is able to take oral therapy, has good aspergillosis, but the sensitivity and specificity of this test are low, and in most instances the test becomes positive as a paintestinal function, and is eating and not taking drugs that induce the metabolism of cytochrome P-450 (e.g., rifampin, phenytoin, tient's condition starts to improve after initiation of therapy. However, detecting antibodies may be useful for patients with phenobarbital, or carbamazepine), then itraconazole would be a reasonable first choice. Patients with intestinal problems (such as chronic invasive aspergillosis.
Molecular diagnostic approaches are in their infancy but are graft-versus-host disease) and patients with AIDS absorb itraconazole poorly. For adults, the dose of itraconazole should be 200 likely to become clinical reality over the next decade. Detection of Aspergillus DNA in blood would be most useful [231] . mg t.i.d. for 4 days, followed by 200 mg twice daily [235] ; all doses of capsules should be taken with food, but the liquid Pulmonary specimens may yield false-positive results because of the presence of extraneously introduced or colonizing spores formulation should be taken without food. Higher doses may be helpful for patients with cerebral aspergillosis [236] (table 7) . [232 -234] . In addition, information on susceptibility is not obtained.
Serum concentrations of itraconazole should be measured 5-10 days after treatment is begun. Interactions with other drugs are Thus, the diagnosis of invasive aspergillosis is based ideally on histological documentation of typical hyphae and a positive problematic, including that with cyclosporine (halve dose and measure levels), digoxin (monitor levels), antihistamines (stop), culture for Aspergillus. In clinical practice such a diagnosis is infrequently achieved, and clinical management has to proceed and protease inhibitors (observe patients carefully). If a patient is not a suitable candidate for oral therapy as pragmatically with the accumulation of symptomatic, radiological, and microbiological criteria that offer different levels of outlined above, then intravenous therapy is necessary. The dose of conventional amphotericin B should be 0.8 -1.0 mg/(kgrd), certainty of the diagnosis. Waiting for definitive proof of a diagnosis of invasive aspergillosis before therapy is initiated regardless of the presence of renal dysfunction; neutropenic patients, for whom 1 -1.25 mg/(kgrd) is appropriate, are the in patients with this disease places such patients in mortal danger from progression of the disease. However, for patients exception. The degree of renal dysfunction can be reduced by administering saline, and the degree of hypokalemia can be with chronic invasive aspergillosis, diagnostic procedures should proceed therapy. Anticipating the pace of the disease reduced by administering amiloride. If renal dysfunction is or is likely to be a major problem, as in cyclosporine-treated is critically important in determining optimal management. patients or patients intolerant of amphotericin B or the fungal Treatment infection progresses despite treatment with an adequate dose of conventional amphotericin B, then one of the lipid-associated The mortality associated with invasive aspergillosis is nearly 100% if the disease is not treated [107] . The only untreated preparations of amphotericin B in doses of 4 -5 mg/(kgrd) (or / 9c4a$$ap40 03-10-98 10:26:38 cida UC: CID itraconazole) is appropriate [237 -243] . Recent data on patients progressive disease, the evaluation of response after 10-20 days of therapy can usually be made on the basis of clinical and with invasive pulmonary aspergillosis whose neutropenia resolved are consistent with the suggestion that 1 mg/(kgrd) of radiological criteria. The less immunocompromised the patient, the longer it takes to evaluate response. Many patients will reAmBisome (Nexstar, San Dimas, CA) is equivalent to 4 mg/(kgrd), although the failure rates with both regimens were spond to alternative therapy if first-line therapy fails. There is no a priori total dose of amphotericin B that should be considerable [244] . Recommended doses of Amphocil (Amphotec; Sequus Pharmaceuticals, Menlo Park, CA) and Abelcet given. The key to success is giving a high enough dose in the first 2 weeks of therapy and switching therapy if it is failing. Some (Liposome Co., Princeton, NJ) are 4 mg/(kgrd) and 5 mg/ (kgrd), respectively. These dosages are my preferred option, clinicians give 2 g or 2.5 g of amphotericin B, but there is no scientific basis for this practice. Consolidation therapy with itracoat least until the progression of disease has been arrested. These dosages should be continued for at least 2 weeks, until a theranazole is often appropriate, often for long periods. Relapse occurs even after months of therapy if patients remain immunocompropeutic response has been obtained.
Unfortunately, first-line therapy fails in at least 50% of patients. mised. Bone marrow transplantation or further cancer chemotherapy may be possible for patients with invasive aspergillosis during Deciding when therapy has failed can be difficult. For patients with rapidly progressive disease, failure of the first regimen remission induction therapy if secondary prophylaxis is administered [245] [246] [247] [248] [249] . Caution should be exercised in using azoles for means a fatal outcome. However, for patients with more slowly this indication as they may potentiate chemotherapy toxicity by interfering with the metabolism of some cytotoxic agents [250] . Several novel agents are under investigation, including [38] . tial variations from patient group to patient group and within each patient group. For patients with leukemia, achieving comFurthermore, ''in vivo resistance'' of A. fumigatus to amphotericin B that cannot yet be detected by in vitro susceptibility plete remission is critical to survival [257] . Avoidance of hemoptysis by performing surgery, even during episodes of protesting has been shown in an animal model [254] . Given the development of resistance, more aggressive performance of found neutropenia, is critical to the survival of patients with proximal lung disease. Cerebral aspergillosis is still associated cultures to detect Aspergillus for species-specific identification and susceptibility testing is appropriate.
with a mortality of ú95% among immunocompromised patients. Advances in therapy for invasive aspergillosis will follow from a greater understanding of pathogenesis, better and Surgical Excision more sensitive diagnostics, education of clinicians, developSurgery has value in the treatment of focal invasive pulmoment of superior antifungal agents, and, possibly, adjunctive nary aspergillosis, for persisting lung shadows before bone immunotherapy. marrow transplantation or for more aggressive chemotherapy, for significant hemoptysis, and for lesions impinging on the great vessels or major airways [118, 127, 145, 246, 247, 255] .
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